Structure-based drug design of novel ASK1 inhibitors using a fully integrated lead optimization strategy
收藏数据链接：
官方服务：
资源简介：
Structure-based drug design of novel ASK1 inhibitors using a fully integrated lead optimization strategy Descriptor: Mitogen-activated protein kinase kinase kinase 5, N-(1-ethyl-1H-pyrazol-4-yl)furan-3-carboxamide Authors: Dougan, D.R, Lawson, J.D, Lane, W. Deposit date: 2017-03-01 Release date: 2017-03-29 Last modified: 2024-03-06 Method: X-RAY DIFFRACTION (3.1 Å) Cite: Structure-based drug design of novel ASK1 inhibitors using an integrated lead optimization strategy. Bioorg. Med. Chem. Lett., 27, 2017
创建时间：
2017-03-01
